CLINICAL_TRIALS
trial_result
· 2013-08-02
Clinical Trial Update: Gene Therapy for X-CGD [Phase 1, Phase 2]
Summary
A gene therapy trial for X-linked Chronic Granulomatous Disease is in Phase 1/Phase 2, with the current status not disclosed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hubert Serve, Prof., MD | Conditions: X-linked Chronic Granulomatous Disease | Phase 1, Phase 2 | Status: UNKNOWN